Small Molecule Therapeutics for Schizophrenia
Springer International Publishing (Verlag)
978-3-319-11501-6 (ISBN)
Antipsychotics and the Dopamine-Serotonin Connection.- GLYT1 Inhibitors: From Hits to Clinical Candidates.- Metabotropic Glutamate Receptor 2 Activators.- Activation of the mGlu5 Receptor for the Treatment of Schizophrenia and Cognitive-Deficit-Associated Disorders.- Muscarinic Acetylcholine Receptor Activators.- Nicotinic Acetylcholine Receptor Modulators.-The Use of PDE10A and PDE9 Inhibitors for Treating Schizophrenia.
From the book reviews:
"The target audience ... is primarily researchers in psychopharmacology involved in drug development. ... Each chapter concludes with citations of the pertinent scientific literature. This book covering small molecular therapeutics for schizophrenia would be a useful review for researchers studying this area." (Michael Joel Schrift, Doody's Book Reviews, March, 2015)
Erscheint lt. Verlag | 30.10.2014 |
---|---|
Reihe/Serie | Topics in Medicinal Chemistry |
Zusatzinfo | VII, 323 p. 185 illus., 23 illus. in color. |
Verlagsort | Cham |
Sprache | englisch |
Maße | 155 x 235 mm |
Gewicht | 660 g |
Themenwelt | Medizin / Pharmazie ► Medizinische Fachgebiete ► Psychiatrie / Psychotherapie |
Medizin / Pharmazie ► Pharmazie | |
Medizin / Pharmazie ► Studium | |
Naturwissenschaften ► Biologie ► Biochemie | |
Naturwissenschaften ► Biologie ► Humanbiologie | |
Naturwissenschaften ► Chemie ► Physikalische Chemie | |
Schlagworte | 5HT Receptor Ligands • DA Receptor Ligands • Emergent Targets • GLYT1 Inhibitors • mACh Activators • mGlu2 Activators • mGlu5 Positive Allosteric Modulators • Muscarinic ACh • nACh Activators • Nicotinic ACh Receptor Activators • PDE10/PDE9 Inhibitors • Psychopharmacology • Second Generation Antipsychotics |
ISBN-10 | 3-319-11501-4 / 3319115014 |
ISBN-13 | 978-3-319-11501-6 / 9783319115016 |
Zustand | Neuware |
Haben Sie eine Frage zum Produkt? |
aus dem Bereich